– ISRAEL, Jerusalem – Alpha Tau Medical Ltd. (Nasdaq: DRTS / DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced the appointment of Nadav Kidron to its Board of Directors.
“Nadav is a fantastic addition to the Board,” said CEO and Chairman, Uzi Sofer. “He has spent many years in a position much like ours, at the helm of a public company innovating a therapeutic modality for patients, and I am sure that he will prove to be an immensely valuable asset to the Company in executing our strategy as we continue to move closer towards commercialization. We look forward to benefitting from his insights and experience in the coming years.”
About Nadav Kidron
Nadav Kidron was appointed President, CEO, and director of Oramed in March 2006, and Chairman of the board effective as of June 30, 2022. He is also Chairman of the board of MDG Real Estate Global, Ltd., director of Israel Advanced Technology Industries Organization, and until 2016 was a director of Entera Bio Ltd. In 2009, he was a fellow at the Merage Foundation for U.S.-Israel Trade Programs for executives in the life sciences field. From 2003 to 2006, Nadav Kidron was the managing director of the Institute of Advanced Jewish Studies at Bar Ilan University. From 2001 to 2003, he was a legal intern at Wine, Mishaiker & Ernstoff Law Offices in Jerusalem, Israel.
“I am delighted to join Alpha Tau’s Board of Directors,” said Nadav Kidron. “The Company is making incredible strides towards revolutionizing the field of oncology therapeutics, and I look forward to contributing to that critical mission.”
Nadav Kidron holds an LL.B. and an International MBA from Bar Ilan University, Israel.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
For more: https://www.alphatau.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.